Slim Adcomm Majority Boosts Sarepta’s Gene Therapy In Duchenne Muscular Dystrophy

 
• By Derrick Gingery
  
Sarepta SRP-9001 AC vote
An FDA official announces the advisory committee vote. • Source: Screenshot of FDA broadcast
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers